Search
Human C1-esterase inhibitor
go.drugbank.com/drugs/DB06404ApprovedInvestigationalThe disease is characterized by acute attacks of painful, and in some cases, fatal swelling of several soft tissues or edema, which may last up to five days when untreated.[L16586, L16606] … The primary function of endogenous C1INH is to regulate the activation of the complement and contact system pathways.
Products: CİNRYZE 500 IU/5 ML IV ENJEKSİYONLUK ÇÖZELTİ İÇİN LİYOFİLİZE TOZ VE ÇÖZÜCÜ, 2 ADETTrastuzumab
go.drugbank.com/drugs/DB00072ApprovedInvestigationalIn November 2023, trastuzumab was also approved by the EMA under the brand name Herwenda.[L49339] … It displays biosimilar properties as Herceptin according to clinical data.
Products: HERCEPTIN 150 MG İNFÜZYONLUK ÇÖZELTİ İÇİN KONSANTRE TOZ, KANJİNTİ 150 MG İNFÜZYONLUK ÇÖZELTİ HAZIRLAMADA KULLANILACAK KONSANTRE İÇİN TOZ, 1 ADETGemtuzumab ozogamicin
go.drugbank.com/drugs/DB00056ApprovedInvestigationalBy binding to the CD33 antigen on tumors, the cytotoxic agent blocks the growth of cancerous cells and causes cell death. … On September 1 2017, gemtuzumab ozogamicin was again approved for the treatment of adults with newly diagnosed CD33-positive acute myeloid leukemia but with a lower dosing regimen and a different schedule
Products: MYLOTARG 5 MG IV İNFÜZYONLUK ÇÖZELTİ HAZIRLAMADA KULLANILACAK KONSANTRE İÇİN TOZ, 1 FLAKONRasburicase
go.drugbank.com/drugs/DB00049ApprovedInvestigationalRasburicase is a recombinant urate-oxidase enzyme produced by a genetically modified <i>Saccharomyces cerevisiae</i> strain.
Products: FASTURTEC 1,5 MG/1 ML INFIZYONLUK COZELTI ICIN TOZ VE COZUCU, 1 ADET, FASTURTEC 7,5 MG/5 ML INFIZYONLUK COZELTI ICIN TOZ VE COZUCU, 1ADETModerate to Severe Chronic Plaque Psoriasis
go.drugbank.com/conditions/DBCOND0032024Synonyms: Moderate-to-severe Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque PsoriasisModerate to Severe Glabellar Frown Lines
go.drugbank.com/conditions/DBCOND0042188Synonyms: Moderate to Severe Glabellar Line, Moderate to Severe Glabellar LinesModerate to Severe Keratoconjunctivitis Sicca (KCS)
go.drugbank.com/conditions/DBCOND0074985Drugs: CyclosporineSynonyms: Moderate to Severe Keratoconjunctivitis Sicca (KCS)Non-responsive to TB Standard Therapy
go.drugbank.com/conditions/DBCOND0154323Drugs: PretomanidSynonyms: Non-responsive to TB Standard Therapy1 to 5 years post-menopausal
go.drugbank.com/conditions/DBCOND0021987Drugs: TestosteroneSynonyms: 1 to 5-year post-menopause, 1 to 5 years post-menopauseIntolerant to other osteoporosis prevention medications
go.drugbank.com/conditions/DBCOND0134318Synonyms: Intolerant to other osteoporosis prevention medications